Respiratory syncytial virus vaccination among US adults aged ≥60 years
2024

RSV Vaccination Coverage in US Adults Aged 60 and Older

Sample size: 49322 publication 10 minutes Evidence: moderate

Author Information

Author(s): Geng Xiaozhen, Wang Wenjun

Primary Institution: Department of Infectious Diseases, Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

Hypothesis

What factors influence RSV vaccination uptake among US adults aged 60 and older?

Conclusion

RSV vaccination coverage among US adults aged 60 and older is 22.2%, with significant disparities based on race, socioeconomic status, and geographic location.

Supporting Evidence

  • RSV vaccination coverage was estimated at 22.2% among US adults aged ≥60 years.
  • Vaccination rates varied significantly by age, with higher rates in older age groups.
  • Racial disparities were evident, with lower coverage among Hispanics and non-Hispanic Blacks.

Takeaway

Only about 1 in 5 older adults in the US have received the RSV vaccine, and some groups are getting vaccinated less than others.

Methodology

This cross-sectional study analyzed data from the US Census Household Pulse Survey, which included 49,322 adults aged ≥60 years who self-reported their RSV vaccination status.

Potential Biases

Potential selection bias due to low response rates and reliance on self-reported vaccination status.

Limitations

The study had low response rates and relied on self-reported data, which may introduce biases.

Participant Demographics

Participants included 47% men and 53% women, with a racial composition of 73.5% non-Hispanic White, 10.3% Hispanic, and 9.6% non-Hispanic Black.

Statistical Information

Confidence Interval

95% CI, 21.6%-22.7%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fimmu.2024.1427550

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication